Compare LENZ & DNMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LENZ | DNMX |
|---|---|---|
| Founded | 2019 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.4M | 265.6M |
| IPO Year | 2021 | N/A |
| Metric | LENZ | DNMX |
|---|---|---|
| Price | $9.97 | $9.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $45.60 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 62.9K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | N/A |
| Revenue This Year | $51.35 | N/A |
| Revenue Next Year | $198.33 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.25 | $9.87 |
| 52 Week High | $50.19 | $9.99 |
| Indicator | LENZ | DNMX |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 63.08 |
| Support Level | $8.99 | $9.90 |
| Resistance Level | $10.29 | $9.99 |
| Average True Range (ATR) | 0.68 | 0.01 |
| MACD | 0.25 | 0.00 |
| Stochastic Oscillator | 87.82 | 100.00 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Dynamix Corp III is a blank check company.